India — Medical Aesthetics & Cosmetic Dermatology: Consumer–Provider Matching Platforms + Procedure GMV Directory
Compiled June 11, 2026 · 22 India platforms profiled — dermatologists, aesthetic doctors & medical/cosmetic procedures only (salon & spa booking excluded by scope) · ISAPS 2024 India page verified vs official PDF · key financials adversarially fact-checked against RoC filings
Platforms & Players
Procedure Directory & GMV Ranking
Methodology & Sources
Platforms profiled
22
Doctor discovery · surgery marketplaces · medical tourism · clinic chains
Only unicorn
Pristyn Care
~$1.17B; elective + cosmetic surgery marketplace
Top platform revenue
Practo ₹234 Cr
FY25; first profitable year (derm is a core vertical)
India medical-aesthetics mkt
~$1.5–2.1B
2024; KPMG dermatology mkt ₹16,000 Cr (2025)
ISAPS 2024 rank
#7 globally
1.29M procedures by plastic surgeons, +25% YoY
Read the categories carefully. Genuine consumer→independent-doctor/clinic matching platforms: Practo, Pristyn Care, HexaHealth, Credihealth, and the medical-tourism players (Vaidam, MediGence, Lyfboat, ClinicSpots). Doctor-backed telederm (part platform, part Rx commerce): CureSkin, Clinikally. D2C product brands with a consult layer (Traya, Mosaic/Man Matters, SkinKraft/Vedix, The Derma Co) and clinic chains (Oliva, Kaya, VLCC, Eugenix, La Densitae, ISAAC Luxe) are shown as labeled context — they are NOT cross-brand marketplaces. Revenue is ₹ crore; confidence High=RoC/official, Medium=credible/partial, Low=third-party/stale.
Latest annual revenue (₹ crore)
Bar color = confidence: blue RoC/official · orange credible/partial · gray third-party/stale. Product brands & chains shown as context.
Total funding raised (US$M)
Cumulative disclosed funding; Pristyn Care is the only unicorn (~$1.17B valuation)
Web traffic: India platforms are overwhelmingly app- and consult-led; clean monthly-visit data isn't reliably published, so it is omitted rather than shown thinly. Scale is captured via users/doctors/cities in the table.
Full India directory — click any column to sort
Hover Notes/Model cells for detail. Sources link to the primary source per platform.
India procedures 2024 (ISAPS)
1.29M
By plastic surgeons only · 677K surgical + 612K non-surgical
Est. GMV (covered)
~₹10,800 Cr
~$1.3B incl. hair transplant est. — see method
#1 by GMV
Hair transplant
~₹4,000 Cr (est. 400K/yr × ₹1L) — India a global hub
#1 non-surgical volume
Laser hair removal
208,880 — India ranks #1 in the world for LHR
#1 surgical volume
Scar revision
106,120 — India #1 surgical category (15.7%)
GMV = India volume × India typical price (₹). Volumes are the ISAPS 2024 India page (verified vs the official PDF) — but ISAPS counts plastic surgeons only (India ≈ 2,800), and excludes the ~17,000+ dermatologists and thousands of cosmetologists who perform most non-surgical work and most hair transplants. So non-surgical and hair-transplant volumes here are a plastic-surgeon-only floor — real India volumes are several-fold higher. Hair transplant (not an ISAPS category) uses an industry volume estimate and is flagged Low. Treat this as a directional ranking; the top-line cross-checks against KPMG's ₹16,000 Cr India dermatology market (2025).
Top procedures by estimated GMV (₹ crore)
Blue = surgical · green = non-surgical · saffron = hair transplant (estimate)
India volume 2024 — ISAPS (plastic surgeons only)
Laser hair removal & scar revision lead volume; surgery leads rupees
India cosmetic dermatology & aesthetics procedure directory — ranked by GMV (volume × price)
Volumes: ISAPS Global Survey 2024, India page (verified). Prices: India clinic/aggregator pages 2024–26 (₹, pre-GST). Hair transplant volume is an industry estimate.
Supplementary procedures — no reliable India volume exists
ISAPS doesn't track these (dermatologist/cosmetologist-delivered, which dominate India). Shown with India prices instead of a GMV rank.
Methodology
Research process
This is the India edition of the same study, built on the same pipeline: parallel research passes (India platforms · India procedure volumes & prices) across RoC filings (via Entrackr/Inc42/Tracxn/TheKredible), ISAPS, KPMG and market-research houses, then adversarial re-verification of the ten most load-bearing figures. ISAPS India per-procedure figures were confirmed digit-for-digit against the official PDF and independent coverage. One unverifiable sub-claim (Practo's "~40 co-branded derm clinics") was dropped.
Platform rankings
Revenue (₹ crore): RoC/MCA filings where available (Practo, Pristyn Care FY24, CureSkin FY24, Mosaic, Traya, Vaidam, Clinikally, VLCC, Eugenix). Some FY25 results aren't filed yet (Pristyn Care) — flagged. Oliva (~$40M) and Credihealth (FY17) are third-party/stale, marked Low and gray.
Scope: India only; actual doctors and medical/cosmetic procedures only. Salon, spa and beauty-booking platforms (Urban Company, Yes Madam, etc.) are excluded. D2C product brands (Traya, Mosaic, SkinKraft/Vedix, The Derma Co) and single-brand clinic chains (Oliva, Kaya, VLCC, Eugenix, La Densitae, ISAAC Luxe) are included as labeled context — their consults/bookings route only to their own products or doctors, so they are not cross-brand marketplaces.
Funding/valuation: disclosed cumulative funding and latest valuation marks (Pristyn Care unicorn; Practo pre-IPO talks ~$700M).
Procedure GMV = India volume × India price
Volumes: ISAPS Global Survey 2024 (published June 2025), India country page — extrapolation to India's ~2,800 board-certified plastic surgeons. India ranks #7 globally (1,288,840 procedures, +25.3% YoY); #1 worldwide for laser hair removal.
Prices (₹): India clinic and aggregator pages (Oliva, Pristyn Care, Practo, IndiCure, Lybrate, HexaHealth, Skinfinity, Eugenix) 2024–26; typical midpoints, pre-GST (18% GST applies on cosmetic procedures). Basis and confidence shown per row.
Known bias (acute for India): ISAPS counts plastic surgeons only, but India's non-surgical and hair-transplant volume runs overwhelmingly through dermatologists, cosmetologists and dedicated chains — so those GMV rows are a floor. Hair transplant is not an ISAPS category; its ~400K/yr volume is an industry estimate (Low confidence) and dominates the ranking, consistent with India being a global hair-transplant hub.
Cross-checks: covered-procedure GMV ≈ ₹10,800 Cr (~$1.3B) sits below India's total medical-aesthetics market ($1.5–2.1B, 2024) and KPMG's ₹16,000 Cr dermatology market (2025) — as expected for a plastic-surgeon-anchored floor.
Currency
₹ is primary. USD conversions at ₹85/US$ where shown.
Key caveats
Anything marked Low confidence or gray should be re-verified before external use.
Pristyn Care figures are FY24 (FY25 not yet filed); its ~$1.17B valuation is a third-party mark, not a closed round.
Practo's figure is whole-company; its dermatology share of consults is not disclosed.
Several ISAPS India per-procedure counts repeat exact values (e.g., HA fillers and liposuction both 97,160) — an artifact of ISAPS's respondent-weighted extrapolation, not an error.